Metabolite-inspired compounds show promise for ulcerative colitis drug discovery

Two structurally modified compounds derived from an anti-inflammatory metabolite demonstrated enhanced anti-inflammatory enactment successful experimental ulcerative colitis successful mice and quality tissue, offering an underexplored cause find accidental for this chronic inflammatory disease, according to a survey led by researchers successful the Institute for Biomedical Sciences astatine Georgia State University.